What Does Prednisone Do to Your Body?

Prednisone mimics your body’s stress hormone. Learn how this powerful medicine affects your immune system, metabolism, and long-term regulatory health.

Prednisone is a synthetic corticosteroid that dials down inflammation and suppresses the immune system, but it also reshapes metabolism, weakens bones, shifts mood, and can disrupt nearly every organ system in the body when used beyond a few days. It works by mimicking cortisol, the hormone your adrenal glands produce naturally in response to stress. That mimicry is powerful enough to control severe asthma flares, autoimmune diseases, and organ transplant rejection, but it comes with a long list of trade-offs that affect how you feel, how you look, and how your body functions at a cellular level.

How Prednisone Actually Works Inside Your Cells

Prednisone itself is not the active drug. Your liver converts it into prednisolone, the form that actually binds to glucocorticoid receptors inside your cells. Once prednisolone reaches those receptors, it enters the cell nucleus and changes which genes get turned on or off. The two main things it does at the genetic level are called transactivation and transrepression. Transactivation switches on anti-inflammatory proteins. Transrepression shuts down the activity of NF-kappa B, a major driver of inflammation that would otherwise crank out signals telling your immune system to attack. The net result is a dramatic cooling of the inflammatory response, which is exactly what you want when your immune system is in overdrive. The problem is that glucocorticoid receptors sit in cells throughout your body, not just in inflamed tissue. So the drug’s reach extends well beyond its intended target.

People with significant liver disease may not convert prednisone to prednisolone as efficiently, which can affect how well the drug works or how it is metabolized. In those cases, doctors sometimes prescribe prednisolone directly to skip the liver conversion step.

What Happens to Blood Sugar and Body Fat

One of the earliest metabolic changes you may notice on prednisone is rising blood sugar, sometimes within hours of the first dose. The drug pushes your liver to produce more glucose while simultaneously making your muscles less responsive to insulin, the hormone that normally shuttles glucose into cells. Research on patients with inflammatory rheumatic diseases found that even low-dose prednisolone increased the liver’s glucose output and reduced the ability of insulin to suppress that output, while also decreasing how efficiently muscles took up glucose. If you already have diabetes or prediabetes, this effect can spike your readings enough to require medication adjustments. Even people with previously normal blood sugar can develop steroid-induced diabetes during longer courses.

Chronic glucocorticoid exposure also appears to rewire the liver’s glucose-producing machinery through molecular pathways that operate independently of classic insulin signaling. That means even when insulin levels are technically adequate, the liver keeps overproducing glucose through a parallel route. This helps explain why blood sugar can be so stubbornly hard to control in people on long-term prednisone.

Then there is the body-shape change that people on chronic steroids dread. Prednisone promotes fat redistribution, moving it from your limbs to your face, the back of your neck, and your abdomen. This is sometimes called a “Cushingoid” appearance because it mirrors Cushing’s syndrome, a condition of cortisol excess. A prospective study tracking corticosteroid-induced fat redistribution found that roughly two-thirds of patients developed it within the first three months, and about seven in ten had it by one year. The classic “moon face” is the most visible sign, but the metabolic consequences of visceral fat accumulation around the organs matter more for long-term health.

Bones and Muscles Under Siege

Glucocorticoid-induced osteoporosis is one of the most serious long-term consequences of prednisone use. The pattern is distinctive: first, bone breakdown speeds up; then, bone building slows dramatically and stays suppressed for as long as you take the drug. At the cellular level, prednisone decreases the number and lifespan of osteoblasts (the cells that build new bone) while prolonging the lifespan of osteoclasts (the cells that break bone down). It also promotes programmed death of osteocytes, the cells embedded in bone that sense mechanical stress and coordinate repair. The result is bone that gets progressively thinner and more fragile, with the spine and hips most affected. Much of this bone loss is driven not by increased breakdown, which is the dominant mechanism in postmenopausal osteoporosis, but by the sustained suppression of new bone formation, which makes glucocorticoid-induced osteoporosis a somewhat different disease requiring somewhat different treatment strategies.

Muscles take a hit too. Long-term high-dose use can cause steroid myopathy, a condition marked by weakness and wasting in the muscles closest to your torso: thighs, upper arms, hips, and shoulders. Getting up from a chair, climbing stairs, or lifting your arms overhead may become difficult. This can develop gradually over months, and people sometimes attribute the weakness to the disease being treated rather than to the drug itself. The distinction matters because reducing the steroid dose, when possible, is the primary treatment for steroid myopathy.

Your Immune System on Prednisone

Suppressing the immune system is often the whole point of prescribing prednisone, but the suppression is not selective. The drug does not just quiet the overactive branch of immunity causing your autoimmune disease or allergic reaction. It broadly reduces your body’s ability to fight off infections. Chronic use is most commonly associated with a drop in CD4 T-cells, a type of white blood cell critical for coordinating immune defense. At higher doses, typically around 20 mg daily or more for over a month, the risk of opportunistic infections rises sharply. These are infections caused by organisms that a healthy immune system would normally keep in check, including a fungal pneumonia called Pneumocystis jirovecii, various fungal infections, and certain viral infections like cytomegalovirus.

Even short courses carry measurable risk. A large population-based study found that within the first 30 days after starting oral corticosteroids, the risk of hospital admission for sepsis (a life-threatening response to infection) increased roughly fivefold above baseline, and the risk of venous blood clots and fractures also rose significantly. These elevated risks applied across dose ranges and then gradually dropped after the drug was stopped. This finding is worth emphasizing because many people assume that a brief “dose pack” is essentially harmless. The absolute risk for any individual remains low, but the relative jump is real.

Mood, Sleep, and Mental Health

If you have ever taken a short course of prednisone and found yourself feeling wired, irritable, or strangely euphoric, you are not imagining things. The most common psychiatric effect of short-term use is a state of euphoria or mild mania, where you feel energized, confident, or restless, often with disrupted sleep. Longer courses tend to tip in the opposite direction, toward depressive symptoms. The range of possible neuropsychiatric effects is surprisingly wide, encompassing depression, mania, agitation, delirium, cognitive changes, and in rare cases outright psychosis.

What makes these effects tricky to predict is that they do not reliably scale with dose. While higher doses increase the probability of psychiatric symptoms, case reports have documented psychosis even at low doses. There is no reliable way to predict who will be affected, which makes awareness important: if you notice significant mood or behavioral changes after starting prednisone, bring them up with your prescriber rather than toughing it out. These effects are generally reversible once the drug is tapered or stopped.

Eyes Under Pressure

Prednisone can raise the pressure inside your eyes, a condition known as steroid-induced ocular hypertension. The link was first reported in 1950, and it has been well established since. If left undetected, elevated eye pressure can progress to steroid-induced glaucoma, which causes irreversible damage to the optic nerve and vision loss. A study of patients on systemic steroids for more than eight weeks found that all 200 participants who were monitored developed raised intraocular pressure, and a few also developed cataracts. Posterior subcapsular cataracts, a type that develops at the back of the lens, are the characteristic form associated with steroid use.

The practical takeaway is that if you are on prednisone for more than a few weeks, periodic eye exams are a good idea, particularly baseline intraocular pressure measurements. Most people will not develop full-blown glaucoma, but catching elevated pressure early allows your eye doctor to intervene before permanent damage occurs.

The Gut and the Microbiome

Prednisone on its own is not a major cause of stomach ulcers, but it becomes one when combined with nonsteroidal anti-inflammatory drugs like ibuprofen or naproxen. Research in animal models found that the combination of a steroid with an NSAID markedly increased the severity of gastric lesions compared to the NSAID alone, through a combination of reduced protective prostaglandins, increased neutrophil activation, and disrupted repair of the stomach lining. If you are on prednisone and also taking an NSAID, talk to your doctor about gastroprotection strategies such as a proton pump inhibitor.

A newer area of research involves what glucocorticoids do to your gut microbiome. A study of patients receiving high-dose glucocorticoids for Graves’ eye disease found significant shifts in the diversity and composition of their intestinal bacteria. Three bacterial genera in particular, Faecalibacterium, Streptococcus, and Prevotella, shifted enough to distinguish patients before and after treatment. The gut’s production of short-chain fatty acids, which are important for intestinal health and immune regulation, dropped significantly, while serotonin levels in the gut rose. This is still early-stage research, and it is not yet clear how much of this translates to the lower doses many patients take or what it means for long-term gut health. But it adds another dimension to the drug’s whole-body footprint.

Why You Cannot Just Stop Taking It

When you take prednisone, the synthetic cortisol flooding your system signals your brain to stop telling your adrenal glands to make their own cortisol. Over time, the adrenal glands shrink and lose their capacity to respond. This shutdown of the hypothalamic-pituitary-adrenal (HPA) axis means that if you abruptly stop the drug, your body may be unable to produce enough cortisol on its own, a condition called adrenal insufficiency. Symptoms can range from fatigue and joint pain to dangerously low blood pressure and, in extreme cases, adrenal crisis, which is a medical emergency.

What surprises many patients is how little it takes to cause this suppression. Prolonged therapy is the most common culprit, but research has shown that even short courses of less than four weeks, and doses as low as 5 mg daily, can suppress the HPA axis. In fact, glucocorticoid therapy is the most common cause of adrenal insufficiency overall. Even non-oral routes like inhaled steroids, topical creams, nasal sprays, and joint injections can contribute to adrenal suppression.

Suppression at the level of the adrenals involves actual physical changes: reduced production of both CRH (the brain hormone that starts the cortisol cascade) and ACTH (the pituitary hormone that tells the adrenals to act) leads to adrenal tissue shrinkage or atrophy. Recovery is not instant. Depending on how long you were on the drug and at what dose, it can take weeks to months for your adrenal glands to regain full function. This is why tapering, the gradual reduction of dose over time, is standard practice. The taper gives the HPA axis time to wake back up.

Growth Concerns in Children

Children on prednisone face all the same adult side effects plus an additional one: impaired growth. High-dose steroid treatment can reduce the normal secretion of growth hormone, and stimulation tests sometimes fail to provoke an appropriate growth hormone response during treatment. The drug also directly harms the growth plates in bones by suppressing the cells responsible for new bone formation and promoting the death of those cells. For children with conditions like nephrotic syndrome who may cycle on and off prednisone for years, tracking growth velocity on a standardized chart is essential. Some catch-up growth can occur after the drug is stopped, but prolonged or repeated courses during key growth windows may result in permanent height loss. Pediatricians generally try to use the lowest effective dose and the shortest possible course to limit this impact.

Timing Matters More Than You Might Think

Your body’s natural cortisol production follows a circadian rhythm, peaking early in the morning and dropping at night. Prednisone is usually prescribed to be taken in the morning for this reason: aligning the drug with the natural cortisol peak causes less HPA axis suppression than taking the same dose at bedtime. But for certain conditions, particularly rheumatoid arthritis, the timing story gets more interesting. Morning stiffness in rheumatoid arthritis is driven by a surge of inflammatory molecules in the early hours before dawn. A modified-release formulation of prednisone taken at bedtime, designed to release the drug around 2 a.m., was shown in a randomized trial to be more effective at controlling morning stiffness than an immediate-release dose taken in the morning. The drug’s effect is the same; only the timing of delivery changed. This is an evolving area of pharmacology that may eventually lead to more tailored dosing schedules for other inflammatory conditions as well.

How Quickly Trouble Can Start

There is a common assumption that side effects only accumulate over months of use. That is wrong for certain risks. The large population study mentioned earlier found that the window of greatest danger for sepsis, blood clots, and fractures was within the first 30 days of starting the drug, not after years of exposure. The risk then faded over the following two months. This pattern held true across different doses. It suggests that even the five-day “burst” of prednisone that millions of people receive each year for conditions like bronchitis or allergic reactions is not risk-free. For most healthy individuals the absolute risk remains small, but for someone with other risk factors for blood clots or infections, even a short course warrants a conversation about those risks.

That said, the relationship between dose, duration, and side effects is not a simple straight line. Some effects, like blood sugar spikes and insomnia, appear within hours of the first pill. Others, like osteoporosis and cataracts, are cumulative and build over months. And some, like adrenal suppression, occupy a middle ground where even a couple of weeks of moderate dosing can trigger the problem. All of this argues for an approach where you and your doctor actively weigh the known risks against the benefit being gained, reassess regularly, and use the smallest dose for the shortest time that still controls the disease.

The NSAID Trap and Other Drug Interactions

Beyond the gut-ulcer synergy with NSAIDs already described, prednisone interacts with a surprisingly long list of medications. It can reduce the effectiveness of blood-sugar-lowering drugs, meaning your diabetes medication may need to be increased. It can alter the metabolism of blood thinners like warfarin, requiring more frequent monitoring of clotting time. Certain antifungal medications and antibiotics, particularly those processed by the same liver enzymes, can raise prednisone levels in your blood, intensifying side effects. Vaccines are another consideration: live vaccines are generally avoided while you are on immunosuppressive doses of prednisone because your weakened immune system could potentially develop the infection the vaccine is supposed to prevent. Killed or inactivated vaccines are safe to give, but they may produce a weaker immune response, so timing vaccination around a steroid course is worth discussing with your doctor.

Alcohol deserves a mention as well. Both prednisone and alcohol can irritate the stomach lining and raise blood sugar, so combining them amplifies both risks. Occasional moderate drinking is unlikely to cause a crisis for most people on a short course, but regular or heavy drinking while on chronic prednisone is a recipe for compounding metabolic and gastrointestinal harm.